Revolutionary Keramatrix Wound Dressing Showcased at Vizient Exchange

BioWound Solutions Showcases Keramatrix at Vizient Innovative Technology Exchange

BioWound Solutions, Inc. has announced its participation in the prestigious Vizient Innovative Technology Exchange, where they will present Keramatrix. This groundbreaking product is an advanced keratin-based wound dressing that has been cleared by the FDA under 510(k) regulations. Keramatrix is specifically designed for a variety of wound types, including light to moderately exudating wounds and pressure ulcers.

The event is scheduled for September 24 in Las Vegas and gathers key stakeholders in healthcare, including clinical leaders from Vizient's hospital clients and experts who contribute to clinical outcomes improvement. The Innovative Technology Exchange serves as a unique platform where selected suppliers can showcase their solutions that enhance safety and improve healthcare delivery.

Keramatrix’s formulation is derived from natural keratin, aiming to stimulate the body’s healing processes efficiently. Its structure is designed to support keratinocytes, promoting cellular activity essential for wound closure. With the versatility to handle a range of wounds, including complex pressure injuries up to Stage 4, Keramatrix positions itself as a vital tool for clinicians seeking effective wound management solutions.

Nick Andolino, CEO of BioWound Solutions, expressed the company’s honor in being chosen for this showcase, highlighting the potential of Keramatrix to make a significant impact in patient care. "We believe that demonstrating our innovative technology at the Exchange will illustrate how Keramatrix improves clinical outcomes and enhances the overall safety of wound care practices," he stated.

The Innovative Technology Program by Vizient, which has reviewed over 1,700 product submissions since its inception in 2003, continuously seeks to introduce novel solutions that can reshape the healthcare landscape. Each year, the program selects a handful of suppliers whose products exhibit a commitment to improving healthcare delivery.

Keramatrix is noted not only for its innovative properties but also for its practical applications that support healthcare providers in streamlining treatment protocols. As a prescription device, it allows healthcare professionals to match treatments effectively to specific diagnosis criteria, thereby optimizing patient care pathways.

In addition to Keramatrix, BioWound Solutions offers a comprehensive portfolio of advanced wound care technologies. The company is dedicated to improving outcomes for various wound types and collaborates with hospitals and health systems to tailor therapies that meet individual patient needs.

As part of their commitment to enhancing clinical care, BioWound Solutions is also leveraging advanced digital tools such as their proprietary AI-powered Eligibility Engine™. This technology aids in real-time benefits verification and provides essential clinical education and reimbursement support, making it easier for healthcare providers to navigate the complexities of wound care. It helps standardize protocols and improve operational efficiency, contributing to better patient outcomes.

The Innovative Technology Exchange is a key event for fostering conversations about new products that can influence healthcare delivery models. It allows healthcare professionals to explore the latest advancements and partner with suppliers like BioWound Solutions in the journey toward improved patient care.

For additional information about Keramatrix and BioWound Solutions, including how they can play a role in advancing wound healing and care delivery, interested parties can visit their website or reach out to their media contact, Audrey McLeod, at 800-989-4155 or via email at [email protected].